Brief: Sunshine Lake Pharma Expects HY Loss Attributable RMB590 Million
24/08/2026 16:58
BRIEF-Sunshine Lake Pharma Expects HY Loss Attributable RMB590 Million Aug 24 (Reuters) - Sunshine Lake Pharma Co Ltd 6887.HK:
EXPECTS LOSS ATTRIBUTABLE TO EQUITY SHAREHOLDERS OF RMB590 MILLION FOR SIX MONTHS ENDED JUNE 30, 2026
EXPECTED LOSS WAS PRIMARILY ATTRIBUTABLE TO EASING OF INFLUENZA EPIDEMIC IN FIRST HALF
Further company coverage: 6887.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sunshine Lake Pharma
See all newsBrief: Sunshine Lake Pharma Says Insulin Degludec Injection, Others Obtain Marketing Approval
Brief: Sunshine Lake Pharma Expects HY Loss Attributable RMB590 Million
Brief: Sunshine Lake Pharma Says Zhang Yushuai Purchases 1.5 Million H Shares
Brief: Sunshine Lake Pharma Obtains Nmpa Approval For Insulin Degludec Injection
Brief: Sunshine Lake Pharma Says Controlling Shareholder To Increase Shareholding By Hk$300 Million-Hk$600 Million In Next Six Months